Literature DB >> 10583434

Left atrial systolic function is depressed in idiopathic and preserved in ischemic dilated cardiomyopathy.

F Triposkiadis1, I Moyssakis, L Hadjinikolaou, T Makris, H Zioris, A Hatzizaharias, M Kyriakidis.   

Abstract

BACKGROUND: Left atrial systolic dysfunction, unexplained by altered loading conditions, has been reported in idiopathic dilated cardiomyopathy suggesting left atrial involvement in the myopathic process.
MATERIALS AND METHODS: Seventeen patients with idiopathic dilated cardiomyopathy, 16 with ischemic dilated cardiomyopathy and 18 normal controls were studied with transthoracic echocardiography and cardiac catheterization. Transmitral diastolic flow was evaluated with pulsed Doppler. Left atrial volume (cm3/m2) at mitral valve opening (maximal, Vmax.), onset of atrial systole (P wave of the electrocardiogram, Vp), and mitral valve closure (minimal, Vmin. ) was determined with two-dimensional echocardiography using the biplane area-length method. The left atrial active emptying fraction (ACTEF = [Vp-Vmin.] x 100/Vp) served as an index of systolic function.
RESULTS: The peak early diastolic transmitral flow velocity (cm/sec) was similar in the three groups (idiopathic: 60 +/- 16, ischemic: 58 +/- 20, control: 56 +/- 22; P = NS), whereas the late diastolic transmitral flow velocity was lower but not significantly different in idiopathic compared to ischemic cardiomyopathy, and in both was lower than control (26 +/- 12 vs. 34 +/- 13 vs. 44 +/- 14, respectively; P < 0.05). Vmax. and Vp were similar in idiopathic and ischemic cardiomyopathy and greater than control (44.6 +/- 13.6 vs. 48.2 +/- 18.3 vs. 26.9 +/- 6.2; P < 0.05, and 34.6 +/- 13.4 vs. 30.8 +/- 10.9 vs. 16.7 +/- 3.7, respectively; P < 0.05). ACTEF was lower in idiopathic than in ischemic cardiomyopathy and in the latter it was similar to control (18 +/- 10% vs. 32 +/- 10% vs. 36 +/- 10%, respectively; P < 0.05). Moreover, ACTEF was inversely related to left atrial tension at end-of atrial systole both in idiopathic and in ischemic cardiomyopathy (r2 = 0.52, P = 0.001 and r2 = 0.57, P = 0.0007, respectively). However, at any given level of left atrial tension at end of atrial systole, ACTEF was lower in idiopathic than ischemic cardiomyopathy.
CONCLUSION: Left atrial systolic function is depressed in idiopathic and preserved in ischemic dilated cardiomyopathy despite similar left atrial loading conditions. This finding suggests left atrial myopathy in the former, and may be related to the differences in the response to medical treatment and clinical outcome observed between the two conditions.

Entities:  

Mesh:

Year:  1999        PMID: 10583434     DOI: 10.1046/j.1365-2362.1999.00563.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  11 in total

1.  Augmentation of left atrial contractile function: a herald of iron overload in patients with beta thalassemia major.

Authors:  Reza Shabanian; Giv Heidari-Bateni; Armen Kocharian; Mehdi Mashayekhi; Shahriar Hosseinzadeh; Abdolrazagh Kiani; Mina Izadyar; Leila Koochakzadeh
Journal:  Pediatr Cardiol       Date:  2010-04-11       Impact factor: 1.655

2.  Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3.

Authors:  Christos Zivlas; Filippos Triposkiadis; Stelios Psarras; Gregory Giamouzis; Ioannis Skoularigis; Stavros Chryssanthopoulos; Alkistis Kapelouzou; Steve Ramcharitar; Edward Barnes; Evangelos Papasteriadis; Dennis Cokkinos
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-08-22

3.  Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases.

Authors:  Giovanni Cioffi; Eva Gerdts; Dana Cramariuc; Luigi Tarantini; Andrea Di Lenarda; Giovanni Pulignano; Donatella Del Sindaco; Carlo Stefenelli; Giovanni de Simone
Journal:  Exp Clin Cardiol       Date:  2010

4.  Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.

Authors:  Rosita Zakeri; Gilles Moulay; Qiang Chai; Ozgur Ogut; Saad Hussain; Hiroyuki Takahama; Tong Lu; Xiao-Li Wang; Wolfgang A Linke; Hon-Chi Lee; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2016-10-10       Impact factor: 8.790

Review 5.  Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure.

Authors:  George Karayannis; George Kitsios; Haralambos Kotidis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2007-04-21       Impact factor: 4.214

6.  Echocardiographic assessment of left atrial ejection force and kinetic energy in chronic heart failure.

Authors:  Filippos Triposkiadis; Christos Harbas; George Sitafidis; John Skoularigis; Vassilios Demopoulos; Glafkos Kelepeshis
Journal:  Int J Cardiovasc Imaging       Date:  2007-03-30       Impact factor: 2.357

7.  Assessment of left atrial ejection force in mildly asphyxiated newborns.

Authors:  Abdolrazagh Kiani; Reza Shabanian; Mahsa Rekabi; Armen Kocharian; Giv Heidari-Bateni
Journal:  Iran J Pediatr       Date:  2012-12       Impact factor: 0.364

8.  Assessment of atrial regional and global electromechanical function by tissue velocity echocardiography: a feasibility study on healthy individuals.

Authors:  Miguel Quintana; Peter Lindell; Samir K Saha; Francesca del Furia; Britta Lind; Satish Govind; Lars-Ake Brodin
Journal:  Cardiovasc Ultrasound       Date:  2005-02-18       Impact factor: 2.062

9.  Left atrial geometry and pump function in ischemic cardiomyopathy.

Authors:  Mohammad Abdelghani Abdelzaher; Wael Mohammad Atteia
Journal:  Int J Cardiol Heart Vasc       Date:  2014-10-28

10.  Atrial remodelling in heart failure: recent developments and relevance for heart failure with preserved ejection fraction.

Authors:  Felix Hohendanner; Daniel Messroghli; David Bode; Florian Blaschke; Abdul Parwani; Leif-Hendrik Boldt; Frank R Heinzel
Journal:  ESC Heart Fail       Date:  2018-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.